Vestibular Balance-Cognition Dual-Task Digital System: Development of a Smart Rehabilitation Platform for the Elderly and Prediction of Balance Function Risks
NCT07735078, Recruiting, National Yang Ming Chiao Tung University
Trial 9
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Vestibular Balance-Cognition Dual-Task Digital System: Development of a Smart Rehabilitation Platform for the Elderly and Prediction of Balance Function Risks | ClinicalTrials.gov |
| NCT number | NCT07735078 | ClinicalTrials.gov |
| Status | Recruiting | ClinicalTrials.gov |
| Enrollment | 55 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | National Yang Ming Chiao Tung University | ClinicalTrials.gov |
| Conditions | Vestibular Dysfunction, Dizziness, Falls (Accidents) in Old Age, Balance Assessment, Cognitive Function Decline, Dual-Task Performance | ClinicalTrials.gov |
| Interventions | Instrumented balance and gait assessment using wearable inertial sensors, Questionnaires and paper-based cognitive tests | ClinicalTrials.gov |
| First posted | 2026-07-29 | ClinicalTrials.gov |
| Last updated | 2026-07-29 | ClinicalTrials.gov |
Registered outcomes 22
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Gait speed | Baseline laboratory assessment (single visit in year 1) | Average forward velocity of whole-body progression during walking, calculated as total distance divided by time. | ClinicalTrials.gov |
| Primary | Stride length (m) | Baseline laboratory assessment (single visit in year 1) | Linear distance between two consecutive initial contacts of the same foot. | ClinicalTrials.gov |
| Primary | Step width (m) | Baseline laboratory assessment (single visit in year 1) | Mediolateral distance between consecutive foot placements, representing base of support during gait. | ClinicalTrials.gov |
| Primary | Cadence (steps/min) | Baseline laboratory assessment (single visit in year 1) | Number of steps taken per minute during walking. | ClinicalTrials.gov |
| Primary | Step-to-step variability (%) | Baseline laboratory assessment (single visit in year 1) | Variability of consecutive steps, typically quantified as the coefficient of variation of stride time or step length. | ClinicalTrials.gov |
| Primary | Trunk angular velocity (degrees/s) | Baseline laboratory assessment (single visit in year 1) | Rate of change in trunk segment orientation over time, derived from rotational kinematics. | ClinicalTrials.gov |
| Primary | Trunk angular displacement (degrees) | Baseline laboratory assessment (single visit in year 1) | Magnitude of trunk segment rotation relative to a reference orientation. | ClinicalTrials.gov |
| Primary | Center-of-mass displacement (m) | Baseline laboratory assessment (single visit in year 1) | Spatial excursion of the body's center of mass, typically analyzed in anterior-posterior and mediolateral directions during standing. | ClinicalTrials.gov |
| Primary | Response time (s or ms) | Baseline laboratory assessment (single visit in year 1) | Time elapsed between stimulus onset and initiation of a motor response. | ClinicalTrials.gov |
| Secondary | Montreal Cognitive Assessment-Taiwan version score (0-30points) | Baseline laboratory assessment | Total score on the Montreal Cognitive Assessment-Taiwan version, representing global cognitive function. | ClinicalTrials.gov |
| Secondary | Path tracing completion time (s) | Baseline laboratory assessment | Time required to complete the Color Trails Test-1 task. | ClinicalTrials.gov |
| Secondary | Stroop test score (count as PR1-99%) | Baseline laboratory assessment | Score of Stroop-type task, indicating inhibitory control and selective attention. | ClinicalTrials.gov |
| Secondary | Working memory completion time (s) | Baseline laboratory assessment | Time required to complete the Color Trails Test-2 task. | ClinicalTrials.gov |
| Secondary | Mental rotation accuracy (number of correct responses)(0-16) | Baseline laboratory assessment | Number of correct responses in the mental rotation task, reflecting visuospatial processing ability. | ClinicalTrials.gov |
| Secondary | Mental rotation completion time (s) | Baseline laboratory assessment | Time required to complete the mental rotation task. | ClinicalTrials.gov |
| Secondary | Activities-specific Balance Confidence score (0-100 points) | Baseline laboratory assessment | Total score on the Activities-specific Balance Confidence (ABC) scale, reflecting perceived balance confidence during daily activities; higher scores indicate greater confidence. | ClinicalTrials.gov |
| Secondary | Dizziness Handicap Inventory score (0-100points) | Baseline laboratory assessment | Total score on the Dizziness Handicap Inventory (DHI), representing self-perceived handicap due to dizziness; higher scores indicate greater disability. | ClinicalTrials.gov |
| Secondary | Hospital Anxiety and Depression Scale - Anxiety score (0-21 points) | Baseline laboratory assessment | Subscale score of the HADS assessing anxiety symptoms; higher scores indicate greater anxiety. | ClinicalTrials.gov |
| Secondary | Hospital Anxiety and Depression Scale - Depression score (0-21 points) | Baseline laboratory assessment | Subscale score of the HADS assessing depressive symptoms; higher scores indicate greater depression. | ClinicalTrials.gov |
| Secondary | Visual Vertigo Analogue Scale score ( 0-90points) | Baseline laboratory assessment | Self-reported severity of visually induced dizziness measured using a visual analogue scale; higher scores indicate greater symptom severity. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Mental Rotation | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)